<?xml version="1.0" encoding="utf-8"?>
<IndexPatientGuideline ID="x22728" Name="Guideline Statement 40" IsComponent="true" Changed="20260414T18:05:30" Created="20260407T17:09:37" Published="20260416T09:16:49" SiteBaseUrl="https://www.auanet.org" Locale="" XPowerPath="/Home/Guidelines &amp; Quality/Guidelines/Clinical Guidelines/Clinically Localized Prostate Cancer/Principles of Management/Principles of Radiation/Guideline Statement 40">
  <IGX_Categories Count="0" CategoryIds="" />
  <LingualMaps />
  <Header type="string" UID="faf9fd2842b549d09e761cd943c2be20" label="Header" readonly="false" hidden="false" required="false" indexable="false" CIID="">Guideline Statement 40</Header>
  <BodyCopy type="xhtml" UID="41a2d8598c364193bbfe9ad86d7bcd3c" label="Body Copy" readonly="false" hidden="false" required="false" indexable="false" Height="" CIID="">&lt;p&gt;&lt;strong&gt; &lt;/strong&gt;&lt;strong&gt;When treating the pelvic lymph nodes with radiation, clinicians should utilize IMRT with doses between 45 Gy to 52 Gy. &lt;em&gt;(Strong Recommendation; Evidence Level: Grade B)&lt;/em&gt;&lt;/strong&gt;&lt;/p&gt;</BodyCopy>
  <DiscussionLinkName type="string" UID="b364402056154f78b38cd8d663eaf3ba" label="Discussion Link Name" readonly="false" hidden="false" required="false" indexable="false" CIID="">Discussion</DiscussionLinkName>
  <DiscussionTitle type="string" UID="ceedafe4ad314b5d8d3225bc0083b81c" label="Discussion Title" readonly="false" hidden="false" required="false" indexable="false" CIID="">Discussion</DiscussionTitle>
  <DiscussionBody type="xhtml" UID="9bbbac02721d4eefba59c63ee7ff9007" label="Discussion Body" readonly="false" hidden="false" required="false" indexable="false" Height="" CIID="">&lt;p&gt;As the POP-RT trial&lt;sup&gt;306&lt;/sup&gt; outlined above utilized IMRT for the treatment of the pelvic lymph nodes, the Panel concludes that clinicians should utilize IMRT when treating the nodes electively in high-risk patients. Meanwhile, various reported trials that included pelvic nodal irradiation treated the nodes with doses from 45 Gy to 52 Gy (50 Gy in POP-RT);&lt;sup&gt;306&lt;/sup&gt; as such, the Panel supports this range when nodal radiation is utilized.&lt;/p&gt;</DiscussionBody>
</IndexPatientGuideline>